No abstract

No abstract

Background: Plasma concentrations of Acylation stimulating protein (ASP) and Orexin-A are closely linked to body weight and energy homeostasis. The purpose of this study is to describe the associations of A:O with metabolic risk marker in women. Methods: This is a case control study. Total 382 women were recruited for the study.192 women with metabolic syndrome (WmetS) &190 women without metabolic syndrome (WometS) according to NCEP-ATPIII guidelines. Serum ASP and Orexin-A level were determined by enzyme linked immunosorbent assay. Results: Result indicated that Waist Circumference, Blood pressure, Lipid profile, Glucose (FPG), Insulin resistance (HOMA-IR), ASP and A:O ratio were significantly higher but HDL and Orexin-A level were significantly lower in WmetS than WometS. The correlation of ASP, A:O ratio were positively significant correlated with Waist Circumference (WC), Triglyceride (TG), Glucose (FPG) and negatively significant correlated with High density lipoprotein (HDL), however the orexin-A was negatively significant correlated with WC and TG in WmetS. Conclusion:The study concluded that A:O ratio may be one of the potential biomarker for metabolic syndrome.

No abstract

Background and aim: Anti-inflammatory IL-10, omentin-1 and inflammatory visfatin dysregulation play a role in the development of metabolic syndrome. The objective of this study was to evaluate the association between circulating IL-10, omentin-1 and visfatin concentration and risk of development of type II diabetesin obese with MS children. Methods:Total of 220 obese were enrolled in our case-control study. They were divided according to NCEP ATP III criteria into obese without MS (control) and obese with MS (case) based on their BMI-percentile, obese children subdivided into overweight, obese, severally obese on the basis of BMI (percentile). Fasting blood sample was collected to determine biochemical parameters. Serum IL-10, omentin-1and visfatin plasma level was assessed by ELISA kit method. Association of these proteins with biochemical and anthropometric parameters were studied. Results: Obese children with MS showed a borderline significant decrease in serum IL-10 levels, Omentin-1 levels however, significantly increased in visfatin levels as compared to without MS obese children. In correlation analysis, we found all the three proteins were significantly corelated with BMI (percentile) but visfatin was also corelated with fasting plasma glucose. Interpretation and conclusions: Our study supports the hypothesis that abnormal production of IL-10, omentin-1 and visfatin may contribute to the development of obesity in children, the correlation between MS and the BMI (percentile) may be an effective parameter in identifying obese children and adolescents at risk for MS. Screening the cases with BMI (percentile) for MS is an important factor for establishing an early diagnosis of diabetes.Risk of development of MS may be a diagnostic parameter for obesity-related complications such as Type II DM.